Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#3870 Small bowel neuroendocrine tumor with carcinoid heart disease

Introduction: Patients with neuroendocrine tumors are often misdiagnosed, at least for the first stage of the disease. In fact, carcinoid syndrome is the clinical expression of the vasoactive substances produce. Carcinoid heart disease is a hazardous and irreversible complication especially in late identified cases.

Conference:

Presenting Author:

Authors: Aliane H, Ghomari-Bezzar S,

Keywords: Neuroendocrine, Small bowel,

#3269 A carcinoid heart revealing a neuroendocrine tumor

Introduction: Carcinoid heart disease can occur in patients with a carcinoid tumor and is defined by the presence of right organic valve disease. These are mainly patients with carcinoid syndrome, often with delayed diagnosis. The difficulty of this pathology is due to its rarity and the fact that it involves several medical and surgical specialties.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Aliane H

Authors: Aliane H, Ghomari-Bezzar S,

Keywords: carcinoid heart, unknown primary, immunohistochemical, prognosis,

#3157 Bronchial neuroendocrine tumor

Introduction: Typical (CT) and atypical (CA) carcinoids are rare tumors that account for 1-2% of all primary bronchial tumors. They are malignant tumors because of their local aggressiveness and metastatic potential.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Benamar W, Ghomari-Bezzar S,

Keywords: bronchial neuroendocrine tumor typical (CT) and atypical (CA) carcinoids, liver metastases, differentiated lung neuroendocrine tumor of atypical carcinoid, chromogranin A and synaptophysin, octoscan, serum chromogranine A, octreotide LP,